NatWest Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-11,081
Closed -$897K 376
2015
Q3
$897K Buy
11,081
+1,815
+20% +$158K 0.02% 207
2015
Q2
$824K Sell
9,266
-1,725
-16% -$151K 0.01% 207
2015
Q1
$954K Buy
10,991
+820
+8% +$68.8K 0.01% 225
2014
Q4
$861 Sell
10,171
-351
-3% -$27.4K 0.01% 234
2014
Q3
$743 Sell
10,522
-452
-4% -$32.2K 0.01% 293
2014
Q2
$761K Sell
10,974
-1,621
-13% -$114K 0.03% 301
2014
Q1
$946K Sell
12,595
-65,275
-84% -$4.89M 0.04% 259
2013
Q4
$5.47M Buy
77,870
+11,881
+18% +$776K 0.14% 156
2013
Q3
$4.08M Sell
65,989
-128,490
-66% -$8.31M 0.12% 167
2013
Q2
$12M Buy
+194,479
New +$11.7M 0.17% 105

Other funds holding ESRX

NatWest Group's ESRX Position: Q4 2015 in Review

NatWest Group sold out of Express Scripts Holding Company (ESRX) in Q4 2015, closing a stake of 11,081 shares — an estimated $897K sold.

NatWest Group first reported a position in ESRX in Q2 2013 and held it in 10 quarters. The position peaked at $12M in Q2 2013. 1,295 funds tracked by Wall St. Rank hold ESRX as of Q4 2015.

  • NatWest Group reported no remaining Express Scripts Holding Company position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 11,081 Express Scripts Holding Company shares in Q4 2015, an estimated $897K.
  • NatWest Group first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 10 quarters.
  • NatWest Group's Express Scripts Holding Company position peaked at $12M in Q2 2013.
  • 1,295 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.